StemCyte International, Ltd. (TPEX:4178)
Taiwan · Delayed Price · Currency is TWD 22.70
+0.40 (1.79%)
At close: Oct 31, 2025
StemCyte International Revenue
StemCyte International had revenue of 197.31M TWD in the half year ending June 30, 2025, with 10.24% growth. This brings the company's revenue in the last twelve months to 398.60M, up 9.15% year-over-year. In the year 2024, StemCyte International had annual revenue of 382.69M with 5.49% growth.
Revenue (ttm)
398.60M
Revenue Growth
+9.15%
P/S Ratio
10.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 382.69M | 19.91M | 5.49% |
| Dec 31, 2023 | 362.78M | 15.09M | 4.34% |
| Dec 31, 2022 | 347.69M | -509.38M | -59.43% |
| Dec 31, 2013 | 857.07M | 124.33M | 16.97% |
| Dec 31, 2012 | 732.74M | 205.09M | 38.87% |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hon Hai Precision Industry | 7.42T |
| Taiwan Semiconductor Manufacturing Company | 3.63T |
| Quanta Computer | 1.83T |
| Cathay Financial Holding | 1.17T |
| Fubon Financial Holding | 1.01T |
| ASE Technology Holding | 629.74B |
| Wiwynn | 604.83B |
| MediaTek | 573.54B |